Zhang R, Shao T Y, Shao C L, Qiu J F, Wang Y
Experimental Teaching Center of Basic Medicine, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, China.
Department of Pathogen Biology, School of Basic Medical Sciences, Nanjing Medical University, Key Laboratory of Pathogen Biology of Jiangsu Province, Nanjing, Jiangsu 211166, China.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2022 Apr 7;34(2):149-157. doi: 10.16250/j.32.1374.2021272.
To examine the effects of infection on the proportion, quantity, differentiation and function of mouse and human uterine natural killer cells (uNK cells), so as to explore the role of uNK cells in abortion of early pregnancy caused by infection.
Pregnant mice were injected intraperitoneally with tachyzoites on day 6.5 of pregnancy, and the abortion mouse model caused by infections was constructed. Mouse uterine lymphocytes were isolated on day 9.5 of pregnancy. Human uterine lymphocytes were isolated from fresh human decidual specimens after abortion in normal early pregnancy and co-cultured with tachyzoites of the RH strain for 48 h at /uterine lymphocytes ratios of 0.5:1, 1:1 and 2:1. The phenotypes of mouse uNK cells (CD122, NK1.1, DX5) and human uNK cells (CD3, CD56, CD11b, CD27) and the expression of intracellular cytokines interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) were detected by flow cytometry. Mouse and human uNK cells were sorted by magnetic beads, and the cytotoxicity of uNK cells was tested using the lactate dehydrogenase (LDH) release assay at effector/target cell ratios of 1:1, 5:1, 10:1 and 20:1 with mouse or human uNK cells as effector cells and mouse YAC-1 cells or human K562 cells as target cells.
On day 9.5 of pregnancy, the mouse abortion rate was significantly higher in the infected group than that in the control group (83.02% vs. 3.51%; = 71.359, < 0.001). Significantly lower absolute number of uNK cells [(4 547 ± 1 610) cells/mouse vs. (8 978 ± 3 339) cells/mouse; = 2.000, < 0.05], lower NK1.1 expression on uNK cell surface [(74.53 ± 8.37)% vs. (93.00 ± 1.11)%; = 0.000, < 0.05], higher proportion of NK1.1-DX5-cells [(20.10 ± 8.03)% vs. (5.04 ± 0.68)%; = 0.000, < 0.05], lower proportion of NK1.1 DX5 cells [(21.70 ± 12.48)% vs. (45.75 ± 2.26)%; = 0.000, < 0.05] and higher IFN-γ expression [(16.74 ± 1.36)% vs. (8.13 ± 1.90)%; = 0.000, < 0.05] were detected in the infected group than in the control group, while no significant difference was seen in TNF-α expression between the two groups [(67.98 ± 9.20)% vs. (52.93 ± 10.42)%; = 2.000, > 0.05]. The mouse uNK cells showed a strong cytotoxicity in the infected group, and the cytotoxicity gradually increased with the effector/target cell ratio. The cytotoxicity of uNK cells against YAC-1 cells was 2.30%, 4.32%, 8.12% and 12.65% in the infected group and 1.21%, 1.63%, 2.51% and 3.22% in the control group at effector/target cell ratios of 1:1, 5:1, 10:1 and 20:1, respectively. Following co-culture of human uterine lymphocytes and tachyzoites of the RH strain for 48 h, the proportion [TOX 2:1 group vs. control group: (6.61 ± 1.75)% vs. (17.48 ± 4.81)%; = 7.307, < 0.01], and absolute number of human uNK cells in uterine lymphocytes of human uNK cells in uterine lymphocytes [TOX 2:1 group vs. control group: (12 104 ± 5 726) cells/well vs. (65 285 ± 21 810) cells/well; = 11.540, < 0.01] were significantly lower in the infected group than in the control group. A lower proportion of CD56CD16 NK cells [TOX 2:1 group vs. control group: (25.25 ± 5.90)% vs. (36.03 ± 4.51)%; = 3.213, > 0.05] and higher proportion of CD56CD16 NK cells [TOX 2:1 group vs. control group: (11.15 ± 2.15)% vs. (7.09 ± 2.24)%; = 2.992, > 0.05] were detected in uNK cells in the infected group than in the control group, and the ratio of CD56CD16 cells/CD56CD16 cells was significantly lower in the infected group than in the control group [TOX2:1 group vs. control group: (2.37 ± 0.92) vs. (5.58 ± 2.39); = 8.228, < 0.05]. In addition, the proportion of CD11bCD27 cells in human uNK cells was significantly higher in the infected group than in the control group [TOX 2:1 group vs. control group: (30.28 ± 6.91)% vs. (17.48 ± 4.67)%; = 6.556, < 0.05], while no significant differences were found between the two groups in terms of IFN-γ [TOX 2:1 group vs. control group: (14.13 ± 1.28)% vs. (15.19 ± 1.64)%; = 1.639, > 0.05] or TNF-α expression [TOX 2:1 group vs. control group: (54.76 ± 10.02)% vs. (50.33 ± 3.67)%; = 0.415, > 0.05]. Human uNK cells presented a strong cytotoxicity in the infected group, and the cytotoxicity gradually increased with the effector/target cell ratio. The cytotoxicity of human uNK cells against K562 cells was 11.90%, 28.11%, 49.91% and 73.35% in the infected group and 12.21%, 21.63%, 33.51% and 48.22% in the control group at effector/target cell ratios of 1:1, 5:1, 10:1 and 20:1, respectively.
infection presents diverse effects on the differentiation and secretion ability of mouse and human uNK cells. However, infection causes a reduction in the absolute number and enhances the cytotoxicity of both mouse and human uNK cells.
研究感染对小鼠和人子宫自然杀伤细胞(uNK细胞)比例、数量、分化及功能的影响,以探讨uNK细胞在感染所致早期妊娠流产中的作用。
妊娠第6.5天给孕鼠腹腔注射速殖子,构建感染所致流产小鼠模型。于妊娠第9.5天分离小鼠子宫淋巴细胞。从正常早孕流产后的新鲜人蜕膜标本中分离人子宫淋巴细胞,按0.5:1、1:1和2:1的子宫淋巴细胞比例与RH株速殖子共培养48小时。采用流式细胞术检测小鼠uNK细胞(CD122、NK1.1、DX5)和人uNK细胞(CD3、CD56、CD11b、CD27)的表型以及细胞内细胞因子干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNF-α)的表达。用磁珠分选小鼠和人uNK细胞,以小鼠或人uNK细胞为效应细胞、小鼠YAC-1细胞或人K562细胞为靶细胞,按1:1、5:1、10:1和20:1的效应细胞/靶细胞比例,采用乳酸脱氢酶(LDH)释放法检测uNK细胞的细胞毒性。
妊娠第9.5天,感染组小鼠流产率显著高于对照组(83.02%对3.51%;χ² = 71.359,P < 0.001)。感染组uNK细胞绝对数量显著低于对照组[(4 547 ± 1 610)个/小鼠对(8 978 ± 3 339)个/小鼠;t = 2.000,P < 0.05],uNK细胞表面NK1.1表达降低[(74.53 ± 8.37)%对(93.00 ± 1.11)%;t = 0.000,P < 0.05],NK1.1-DX5-细胞比例升高[(20.10 ± 8.03)%对(5.04 ± 0.68)%;t = 0.000,P < 0.05],NK1.1 DX5细胞比例降低[(21.70 ± 12.48)%对(45.75 ± 2.26)%;t = 0.000,P < 0.05],IFN-γ表达升高[(16.74 ± 1.36)%对(8.13 ± 1.90)%;t = 0.000,P < 0.05],而两组TNF-α表达差异无统计学意义[(67.98 ± 9.20)%对(52.93 ± 10.42)%;t = 2.000,P > 0.05]。感染组小鼠uNK细胞表现出较强细胞毒性,且细胞毒性随效应细胞/靶细胞比例增加而逐渐增强。在效应细胞/靶细胞比例为1:1、5:1、10:1和20:1时,感染组uNK细胞对YAC-1细胞的细胞毒性分别为2.30%、4.32%、8.12%和12.65%,对照组分别为1.21%、1.63%、2.51%和3.22%。人子宫淋巴细胞与RH株速殖子共培养48小时后,感染组人子宫淋巴细胞中uNK细胞比例[TOX 2:1组对对照组:(6.61 ± 1.75)%对(17.48 ± 4.81)%;t = 7.307,P < 0.01]及绝对数量[TOX 2:1组对对照组:(12 104 ± 5 726)个/孔对(65 285 ± 21 810)个/孔;t = 11.540,P < 0.01]均显著低于对照组。感染组uNK细胞中CD56CD16 NK细胞比例降低[TOX 2:1组对对照组:(25.25 ± 5.90)%对(36.03 ± 4.51)%;t = 3.213,P > 0.05],CD56CD16 NK细胞比例升高[TOX 2:1组对对照组:(11.15 ± 2.15)%对(7.09 ± 2.24)%;t = 2.992,P > 0.05],且感染组CD56CD16细胞/CD56CD16细胞比值显著低于对照组[TOX2:1组对对照组:(2.37 ± 0.92)对(5.58 ± 2.39);t = 8.228,P < 0.05]。此外,感染组人uNK细胞中CD11bCD27细胞比例显著高于对照组[TOX 2:1组对对照组:(30.28 ± 6.91)%对(17.48 ± 4.67)%;t = 6.556,P < 0.05],而两组IFN-γ[TOX 2:1组对对照组:(14.13 ± 1.28)%对(15.19 ± 1.64)%;t = 1.639,P > 0.05]及TNF-α表达差异无统计学意义[TOX 2:1组对对照组:(54.76 ± 10.02)%对(50.33 ± 3.67)%;t = 0.415,P > 0.05]。感染组人uNK细胞表现出较强细胞毒性,且细胞毒性随效应细胞/靶细胞比例增加而逐渐增强。在效应细胞/靶细胞比例为1:1、5:1、10:1和20:1时,感染组人uNK细胞对K562细胞的细胞毒性分别为11.90%、28.11%、49.91%和73.35%,对照组分别为12.21%、21.63%、33.51%和48.22%。
感染对小鼠和人uNK细胞的分化及分泌能力有多种影响。然而,感染导致小鼠和人uNK细胞绝对数量减少并增强其细胞毒性。